Stem Cells Market (By Product: Adult Stem Cells, Human Embryonic Stem Cells; By Application; By Technology; By Therapy; By End Use) - Global Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook and Forecast 2022-2030

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis 

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on Stem Cells Market 

5.1. COVID-19 Landscape: Stem Cells Industry Impact

5.2. COVID 19 - Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

Chapter 6. Market Dynamics Analysis and Trends

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global Stem Cells Market, By Product

8.1. Stem Cells Market, by Product, 2022-2030

8.1.1. Adult Stem Cells (ASCs)

8.1.1.1. Market Revenue and Forecast (2017-2030)

8.1.2. Human Embryonic Stem Cells (HESCs)

8.1.2.1. Market Revenue and Forecast (2017-2030)

8.1.3. Induced Pluripotent Stem Cells (iPSCs)

8.1.3.1. Market Revenue and Forecast (2017-2030)

8.1.4. Very Small Embryonic Like Stem Cells

8.1.4.1. Market Revenue and Forecast (2017-2030)

Chapter 9. Global Stem Cells Market, By Application

9.1. Stem Cells Market, by Application, 2022-2030

9.1.1. Regenerative Medicine

9.1.1.1. Market Revenue and Forecast (2017-2030)

9.1.2. Drug Discovery And Development

9.1.2.1. Market Revenue and Forecast (2017-2030)

Chapter 10. Global Stem Cells Market, By Technology 

10.1. Stem Cells Market, by Technology, 2022-2030

10.1.1. Cell Acquisition

10.1.1.1. Market Revenue and Forecast (2017-2030)

10.1.2. Cell Production

10.1.2.1. Market Revenue and Forecast (2017-2030)

10.1.3. Cryopreservation

10.1.3.1. Market Revenue and Forecast (2017-2030)

10.1.4. Expansion And Sub-Culture

10.1.4.1. Market Revenue and Forecast (2017-2030)

Chapter 11. Global Stem Cells Market, By Therapy

11.1. Stem Cells Market, by Therapy, 2022-2030

11.1.1. Autologous

11.1.1.1. Market Revenue and Forecast (2017-2030)

11.1.2. Allogenic

11.1.2.1. Market Revenue and Forecast (2017-2030)

Chapter 12. Global Stem Cells Market, By End-user

12.1. Stem Cells Market, by End-user, 2022-2030

12.1.1. Pharmaceutical & Biotechnology Companies

12.1.1.1. Market Revenue and Forecast (2017-2030)

12.1.2. Hospitals & Cell Banks

12.1.2.1. Market Revenue and Forecast (2017-2030)

12.1.3. Academic & Research Institutes

12.1.3.1. Market Revenue and Forecast (2017-2030)

Chapter 13. Global Stem Cells Market, Regional Estimates and Trend Forecast

13.1. North America

13.1.1. Market Revenue and Forecast, by Product (2017-2030)

13.1.2. Market Revenue and Forecast, by Application (2017-2030)

13.1.3. Market Revenue and Forecast, by Technology (2017-2030)

13.1.4. Market Revenue and Forecast, by Therapy (2017-2030)

13.1.5. Market Revenue and Forecast, by End-user (2017-2030)

13.1.6. U.S.

13.1.6.1. Market Revenue and Forecast, by Product (2017-2030)

13.1.6.2. Market Revenue and Forecast, by Application (2017-2030)

13.1.6.3. Market Revenue and Forecast, by Technology (2017-2030)

13.1.6.4. Market Revenue and Forecast, by Therapy (2017-2030)

13.1.7. Market Revenue and Forecast, by End-user (2017-2030) 

13.1.8. Rest of North America

13.1.8.1. Market Revenue and Forecast, by Product (2017-2030)

13.1.8.2. Market Revenue and Forecast, by Application (2017-2030)

13.1.8.3. Market Revenue and Forecast, by Technology (2017-2030)

13.1.8.4. Market Revenue and Forecast, by Therapy (2017-2030)

13.1.8.5. Market Revenue and Forecast, by End-user (2017-2030)

13.2. Europe

13.2.1. Market Revenue and Forecast, by Product (2017-2030)

13.2.2. Market Revenue and Forecast, by Application (2017-2030)

13.2.3. Market Revenue and Forecast, by Technology (2017-2030)

13.2.4. Market Revenue and Forecast, by Therapy (2017-2030) 

13.2.5. Market Revenue and Forecast, by End-user (2017-2030) 

13.2.6. UK

13.2.6.1. Market Revenue and Forecast, by Product (2017-2030)

13.2.6.2. Market Revenue and Forecast, by Application (2017-2030)

13.2.6.3. Market Revenue and Forecast, by Technology (2017-2030)

13.2.7. Market Revenue and Forecast, by Therapy (2017-2030) 

13.2.8. Market Revenue and Forecast, by End-user (2017-2030) 

13.2.9. Germany

13.2.9.1. Market Revenue and Forecast, by Product (2017-2030)

13.2.9.2. Market Revenue and Forecast, by Application (2017-2030)

13.2.9.3. Market Revenue and Forecast, by Technology (2017-2030)

13.2.10. Market Revenue and Forecast, by Therapy (2017-2030)

13.2.11. Market Revenue and Forecast, by End-user (2017-2030)

13.2.12. France

13.2.12.1. Market Revenue and Forecast, by Product (2017-2030)

13.2.12.2. Market Revenue and Forecast, by Application (2017-2030)

13.2.12.3. Market Revenue and Forecast, by Technology (2017-2030)

13.2.12.4. Market Revenue and Forecast, by Therapy (2017-2030)

13.2.13. Market Revenue and Forecast, by End-user (2017-2030)

13.2.14. Rest of Europe

13.2.14.1. Market Revenue and Forecast, by Product (2017-2030)

13.2.14.2. Market Revenue and Forecast, by Application (2017-2030)

13.2.14.3. Market Revenue and Forecast, by Technology (2017-2030)

13.2.14.4. Market Revenue and Forecast, by Therapy (2017-2030)

13.2.15. Market Revenue and Forecast, by End-user (2017-2030)

13.3. APAC

13.3.1. Market Revenue and Forecast, by Product (2017-2030)

13.3.2. Market Revenue and Forecast, by Application (2017-2030)

13.3.3. Market Revenue and Forecast, by Technology (2017-2030)

13.3.4. Market Revenue and Forecast, by Therapy (2017-2030)

13.3.5. Market Revenue and Forecast, by End-user (2017-2030)

13.3.6. India

13.3.6.1. Market Revenue and Forecast, by Product (2017-2030)

13.3.6.2. Market Revenue and Forecast, by Application (2017-2030)

13.3.6.3. Market Revenue and Forecast, by Technology (2017-2030)

13.3.6.4. Market Revenue and Forecast, by Therapy (2017-2030)

13.3.7. Market Revenue and Forecast, by End-user (2017-2030)

13.3.8. China

13.3.8.1. Market Revenue and Forecast, by Product (2017-2030)

13.3.8.2. Market Revenue and Forecast, by Application (2017-2030)

13.3.8.3. Market Revenue and Forecast, by Technology (2017-2030)

13.3.8.4. Market Revenue and Forecast, by Therapy (2017-2030)

13.3.9. Market Revenue and Forecast, by End-user (2017-2030)

13.3.10. Japan

13.3.10.1. Market Revenue and Forecast, by Product (2017-2030)

13.3.10.2. Market Revenue and Forecast, by Application (2017-2030)

13.3.10.3. Market Revenue and Forecast, by Technology (2017-2030)

13.3.10.4. Market Revenue and Forecast, by Therapy (2017-2030)

13.3.10.5. Market Revenue and Forecast, by End-user (2017-2030)

13.3.11. Rest of APAC

13.3.11.1. Market Revenue and Forecast, by Product (2017-2030)

13.3.11.2. Market Revenue and Forecast, by Application (2017-2030)

13.3.11.3. Market Revenue and Forecast, by Technology (2017-2030)

13.3.11.4. Market Revenue and Forecast, by Therapy (2017-2030)

13.3.11.5. Market Revenue and Forecast, by End-user (2017-2030)

13.4. MEA

13.4.1. Market Revenue and Forecast, by Product (2017-2030)

13.4.2. Market Revenue and Forecast, by Application (2017-2030)

13.4.3. Market Revenue and Forecast, by Technology (2017-2030)

13.4.4. Market Revenue and Forecast, by Therapy (2017-2030)

13.4.5. Market Revenue and Forecast, by End-user (2017-2030)

13.4.6. GCC

13.4.6.1. Market Revenue and Forecast, by Product (2017-2030)

13.4.6.2. Market Revenue and Forecast, by Application (2017-2030)

13.4.6.3. Market Revenue and Forecast, by Technology (2017-2030)

13.4.6.4. Market Revenue and Forecast, by Therapy (2017-2030)

13.4.7. Market Revenue and Forecast, by End-user (2017-2030)

13.4.8. North Africa

13.4.8.1. Market Revenue and Forecast, by Product (2017-2030)

13.4.8.2. Market Revenue and Forecast, by Application (2017-2030)

13.4.8.3. Market Revenue and Forecast, by Technology (2017-2030)

13.4.8.4. Market Revenue and Forecast, by Therapy (2017-2030)

13.4.9. Market Revenue and Forecast, by End-user (2017-2030)

13.4.10. South Africa

13.4.10.1. Market Revenue and Forecast, by Product (2017-2030)

13.4.10.2. Market Revenue and Forecast, by Application (2017-2030)

13.4.10.3. Market Revenue and Forecast, by Technology (2017-2030)

13.4.10.4. Market Revenue and Forecast, by Therapy (2017-2030)

13.4.10.5. Market Revenue and Forecast, by End-user (2017-2030)

13.4.11. Rest of MEA

13.4.11.1. Market Revenue and Forecast, by Product (2017-2030)

13.4.11.2. Market Revenue and Forecast, by Application (2017-2030)

13.4.11.3. Market Revenue and Forecast, by Technology (2017-2030)

13.4.11.4. Market Revenue and Forecast, by Therapy (2017-2030)

13.4.11.5. Market Revenue and Forecast, by End-user (2017-2030)

13.5. Latin America

13.5.1. Market Revenue and Forecast, by Product (2017-2030)

13.5.2. Market Revenue and Forecast, by Application (2017-2030)

13.5.3. Market Revenue and Forecast, by Technology (2017-2030)

13.5.4. Market Revenue and Forecast, by Therapy (2017-2030)

13.5.5. Market Revenue and Forecast, by End-user (2017-2030)

13.5.6. Brazil

13.5.6.1. Market Revenue and Forecast, by Product (2017-2030)

13.5.6.2. Market Revenue and Forecast, by Application (2017-2030)

13.5.6.3. Market Revenue and Forecast, by Technology (2017-2030)

13.5.6.4. Market Revenue and Forecast, by Therapy (2017-2030)

13.5.7. Market Revenue and Forecast, by End-user (2017-2030)

13.5.8. Rest of LATAM

13.5.8.1. Market Revenue and Forecast, by Product (2017-2030)

13.5.8.2. Market Revenue and Forecast, by Application (2017-2030)

13.5.8.3. Market Revenue and Forecast, by Technology (2017-2030)

13.5.8.4. Market Revenue and Forecast, by Therapy (2017-2030)

13.5.8.5. Market Revenue and Forecast, by End-user (2017-2030)

Chapter 14. Company Profiles

14.1. Advanced Cell Technology Inc.

14.1.1. Company Overview

14.1.2. Product Offerings

14.1.3. Financial Performance

14.1.4. Recent Initiatives

14.2. STEMCELL Technologies Inc.

14.2.1. Company Overview

14.2.2. Product Offerings

14.2.3. Financial Performance

14.2.4. Recent Initiatives

14.3. Cellular Engineering Technologies Inc.

14.3.1. Company Overview

14.3.2. Product Offerings

14.3.3. Financial Performance

14.3.4. Recent Initiatives

14.4. CellGenix GmbH   

14.4.1. Company Overview

14.4.2. Product Offerings

14.4.3. Financial Performance

14.4.4. Recent Initiatives

14.5. PromoCell GmbH

14.5.1. Company Overview

14.5.2. Product Offerings

14.5.3. Financial Performance

14.5.4. Recent Initiatives

14.6. Kite Pharma

14.6.1. Company Overview

14.6.2. Product Offerings

14.6.3. Financial Performance

14.6.4. Recent Initiatives

14.7. Lonza

14.7.1. Company Overview

14.7.2. Product Offerings

14.7.3. Financial Performance

14.7.4. Recent Initiatives

14.8. Cellartis AB

14.8.1. Company Overview

14.8.2. Product Offerings

14.8.3. Financial Performance

14.8.4. Recent Initiatives

14.9. Angel Biotechnology

14.9.1. Company Overview

14.9.2. Product Offerings

14.9.3. Financial Performance

14.9.4. Recent Initiatives

14.10. Brainstorm Cell Therapeutics

14.10.1. Company Overview

14.10.2. Product Offerings

14.10.3. Financial Performance

14.10.4. Recent Initiatives

Chapter 15. Research Methodology

15.1. Primary Research

15.2. Secondary Research

15.3. Assumptions

Chapter 16. Appendix

16.1. About Us

16.2. Glossary of Terms